Understanding "Heparin Resistance" in Cardiac Surgery: Altered Heparin Responsiveness and Its Association With Acute Inflammatory Reactions.

Trial Profile

Understanding "Heparin Resistance" in Cardiac Surgery: Altered Heparin Responsiveness and Its Association With Acute Inflammatory Reactions.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Dec 2016

At a glance

  • Drugs Antithrombin alfa (Primary) ; Heparin
  • Indications Blood coagulation disorders
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 07 Jan 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 28 Aug 2014 Planned number of patients changed from 2800 to 500 as reported by ClinicalTrials.gov record.
    • 05 Jun 2012 Planned initiation date changed from 1 May 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top